Compare · ALB vs ZTEK
ALB vs ZTEK
Side-by-side comparison of Albemarle Corporation (ALB) and Zentek Ltd. (ZTEK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALB and ZTEK operate in Major Chemicals (Industrials), so they compete in similar markets.
- ALB is the larger of the two at $13.54B, about 201.2x ZTEK ($67.3M).
- Over the past year, ALB is up 53.7% and ZTEK is down 39.9% - ALB leads by 93.6 points.
- ALB has been more active in the news (15 items in the past 4 weeks vs 4 for ZTEK).
- ALB has more recent analyst coverage (25 ratings vs 0 for ZTEK).
- Company
- Albemarle Corporation
- Zentek Ltd.
- Price
- $114.86-1.74%
- $0.55-0.45%
- Market cap
- $13.54B
- $67.3M
- 1M return
- -22.32%
- +29.26%
- 1Y return
- +53.70%
- -39.89%
- Industry
- Major Chemicals
- Major Chemicals
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 15
- 4
- Recent ratings
- 25
- 0
Albemarle Corporation
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine Specialties, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine Specialties segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines, biocides, disinfectants, and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, crop protection, and custom chemistry services markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
Zentek Ltd.
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.
Latest ALB
- Director Desalles Bartolomeo Eduardo was granted 1,375 shares (SEC Form 4)
- SEC Form 3 filed by new insider Desalles Bartolomeo Eduardo
- Albemarle Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Albemarle Appoints Eduardo Bartolomeo to Board of Directors
- Albemarle Announces Quarterly Common Stock Dividend
- Albemarle Corporation to Release Second Quarter 2026 Earnings Results on Wednesday, August 5, 2026
- Director Collins Michelle T was granted 1,252 shares, increasing direct ownership by 385% to 1,577 units (SEC Form 4)
- SEC Form 4 filed by Director Minor Glenda J
- Director Brlas Laurie was granted 1,286 shares, increasing direct ownership by 21% to 7,289 units (SEC Form 4)
- Director Cramer Ralf Hans covered exercise/tax liability with 942 shares and was granted 1,286 shares, increasing direct ownership by 6% to 5,723 units (SEC Form 4)
Latest ZTEK
- SEC Form 6-K filed by Zentek Ltd.
- SEC Form 6-K filed by Zentek Ltd.
- SEC Form 6-K filed by Zentek Ltd.
- SEC Form 6-K filed by Zentek Ltd.
- SEC Form 6-K filed by Zentek Ltd.
- Amendment: SEC Form 40-F/A filed by Zentek Ltd.
- SEC Form 6-K filed by Zentek Ltd.
- SEC Form 40-F filed by Zentek Ltd.
- SEC Form 6-K filed by Zentek Ltd.
- SEC Form D filed by Zentek Ltd.